Shopping Cart 0
Cart Subtotal
USD 0

Sysmex Corp (6869) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Sysmex Corp (Sysmex) is a supplier of medical devices. It researches, develops, manufactures and sells instruments, reagents, and software applications that facilitate health checkups, treatment and disease management. The company offers diagnostic instruments, reagents and laboratory information systems to clinical laboratories for testing. The solutions that the company offers include heamatology, hemostasis, urinalysis analyzers. It conducts research and development at its facilities in Japan, North America and Europe. The company operates along with its subsidiaries in the Americas, Europe, Middle East, Africa and Asia Pacific. Its products are used by medical institutions. Sysmex is headquartered in Hyogo, Japan.

Sysmex Corp (6869)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Sysmex Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Sysmex Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Sysmex Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Sysmex Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Sysmex Corp, Medical Devices Deals, 2012 to YTD 2018 9

Sysmex Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Sysmex Corp, Pharmaceuticals & Healthcare, Deal Details 11

Partnerships 11

National Cancer Center, JVCKENWOOD, Sysmex and Daiichi Sankyo Enter into Agreement 11

Sysmex Inostics Enters into Distribution Agreement with IndivuTest 12

Merck Serono Enters into Co-Development Agreement with Sysmex Inostics 13

Sysmex Corp-Key Competitors 14

Sysmex Corp-Key Employees 15

Sysmex Corp-Locations And Subsidiaries 16

Head Office 16

Other Locations & Subsidiaries 16

Joint Venture 19

Recent Developments 20

Strategy And Business Planning 20

Aug 16, 2018: Sysmex America opens Center for Learning, expanding training facilities for customers in North America 20

Jul 10, 2018: Sysmex Establishes Subsidiary in Egypt and Begins Conducting Direct Sales and Services 22

Apr 03, 2017: Sysmex Establishes New Company, Sysmex Harmony, to Promote the Employment of People with Disabilities 23

Financial Announcements 24

May 09, 2018: Sysmex Announces Summary of Consolidated Financial Results for the Fiscal Year Ended March 31, 2018 24

Corporate Communications 27

Mar 08, 2018: Sysmex: Announcement of Organizational and Personnel Changes 27

Legal and Regulatory 29

Apr 24, 2018: Sysmex Obtains Certification under ISO Guide 34, the International Standard for the Competence of Reference Material Producers 29

Other Significant Developments 31

Sep 05, 2017: Sysmex Begins Conducting Direct Sales and Services in Ghana 31

Aug 17, 2017: Sysmex to Commence Sales of Revohem PT Reagent for Measuring Prothrombin Time, a Key Testing Parameter for Monitoring Anticoagulation Therapy 32

Appendix 33

Methodology 33

About GlobalData 33

Contact Us 33

Disclaimer 33


List Of Figure

List of Figures

Sysmex Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Sysmex Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Sysmex Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Sysmex Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Sysmex Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Sysmex Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Sysmex Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Sysmex Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Sysmex Corp, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Sysmex Corp, Pharmaceuticals & Healthcare, Key Facts, 2018 2

Sysmex Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Sysmex Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Sysmex Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Sysmex Corp, Deals By Therapy Area, 2012 to YTD 2018 8

Sysmex Corp, Medical Devices Deals, 2012 to YTD 2018 9

Sysmex Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

National Cancer Center, JVCKENWOOD, Sysmex and Daiichi Sankyo Enter into Agreement 11

Sysmex Inostics Enters into Distribution Agreement with IndivuTest 12

Merck Serono Enters into Co-Development Agreement with Sysmex Inostics 13

Sysmex Corp, Key Competitors 14

Sysmex Corp, Key Employees 15

Sysmex Corp, Other Locations 16

Sysmex Corp, Subsidiaries 17

Sysmex Corp, Joint Venture 19

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Sysmex Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Summary

Sysmex Corp (Sysmex) is a supplier of medical devices. It researches, develops, manufactures and sells instruments, reagents, and software applications that facilitate health checkups, treatment and disease management. The company offers diagnostic instruments, reagents and laboratory information systems to clinical laboratories for testing. The solutions that the company offers include heamatology, hemostasis, urinalysis analyzers. It conducts research and development at its facilities in Japan, North America and Europe. The company operates along with its subsidiaries in the Americas, Europe, Middle East, Africa and Asia Pacific. Its products are used by medical institutions. Sysmex is headquartered in Hyogo, Japan.

Sysmex Corp (6869)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Sysmex Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Sysmex Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Sysmex Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Sysmex Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Sysmex Corp, Medical Devices Deals, 2012 to YTD 2018 9

Sysmex Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Sysmex Corp, Pharmaceuticals & Healthcare, Deal Details 11

Partnerships 11

National Cancer Center, JVCKENWOOD, Sysmex and Daiichi Sankyo Enter into Agreement 11

Sysmex Inostics Enters into Distribution Agreement with IndivuTest 12

Merck Serono Enters into Co-Development Agreement with Sysmex Inostics 13

Sysmex Corp-Key Competitors 14

Sysmex Corp-Key Employees 15

Sysmex Corp-Locations And Subsidiaries 16

Head Office 16

Other Locations & Subsidiaries 16

Joint Venture 19

Recent Developments 20

Strategy And Business Planning 20

Aug 16, 2018: Sysmex America opens Center for Learning, expanding training facilities for customers in North America 20

Jul 10, 2018: Sysmex Establishes Subsidiary in Egypt and Begins Conducting Direct Sales and Services 22

Apr 03, 2017: Sysmex Establishes New Company, Sysmex Harmony, to Promote the Employment of People with Disabilities 23

Financial Announcements 24

May 09, 2018: Sysmex Announces Summary of Consolidated Financial Results for the Fiscal Year Ended March 31, 2018 24

Corporate Communications 27

Mar 08, 2018: Sysmex: Announcement of Organizational and Personnel Changes 27

Legal and Regulatory 29

Apr 24, 2018: Sysmex Obtains Certification under ISO Guide 34, the International Standard for the Competence of Reference Material Producers 29

Other Significant Developments 31

Sep 05, 2017: Sysmex Begins Conducting Direct Sales and Services in Ghana 31

Aug 17, 2017: Sysmex to Commence Sales of Revohem PT Reagent for Measuring Prothrombin Time, a Key Testing Parameter for Monitoring Anticoagulation Therapy 32

Appendix 33

Methodology 33

About GlobalData 33

Contact Us 33

Disclaimer 33


List Of Figure

List of Figures

Sysmex Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Sysmex Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Sysmex Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Sysmex Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Sysmex Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Sysmex Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Sysmex Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Sysmex Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Sysmex Corp, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Sysmex Corp, Pharmaceuticals & Healthcare, Key Facts, 2018 2

Sysmex Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Sysmex Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Sysmex Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Sysmex Corp, Deals By Therapy Area, 2012 to YTD 2018 8

Sysmex Corp, Medical Devices Deals, 2012 to YTD 2018 9

Sysmex Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

National Cancer Center, JVCKENWOOD, Sysmex and Daiichi Sankyo Enter into Agreement 11

Sysmex Inostics Enters into Distribution Agreement with IndivuTest 12

Merck Serono Enters into Co-Development Agreement with Sysmex Inostics 13

Sysmex Corp, Key Competitors 14

Sysmex Corp, Key Employees 15

Sysmex Corp, Other Locations 16

Sysmex Corp, Subsidiaries 17

Sysmex Corp, Joint Venture 19

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Sysmex Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.